Characteristics, treatment and outcome of 15 to 18 years-old adolescents with Chronic Myeloid Leukemia (CML): The experience of the International Registry of Childhood CML (I-CML-Ped Study)

Froment, MorganeSuttorp, MeinolfRagot, StephanieDeutsch, HeleneGoyeau, ViolaineDe Moerloose, BarbaraBrandalise, Silvia ReginaBorisevich, MarinaSedlacek, PetrGunes, Adalet MeralLausen, BirgitteMolines Honrubia, AntonioJakovljevic, GordanaVersluys, BirgittaKalwak, KrzysztofHraskova, AndreaMillot, Frederic2024-06-272024-06-272021-11-230006-49711528-0020https://doi.org/10.1182/blood-2021-150438https://ashpublications.org/blood/article/138/Supplement%201/3602/479737/Characteristics-Treatment-and-Outcome-of-15-to-18https://hdl.handle.net/11452/42481eninfo:eu-repo/semantics/openAccessScience & technologyLife sciences & biomedicineHematologyHematologyCharacteristics, treatment and outcome of 15 to 18 years-old adolescents with Chronic Myeloid Leukemia (CML): The experience of the International Registry of Childhood CML (I-CML-Ped Study)Meeting Abstract00073641390616713810.1182/blood-2021-150438